Amneal Pharmaceuticals

Amneal Pharma to invest Rs 1,600 crore in Gujarat to make GLP-1 drugs

Globally, there is a shortage of this new class of diabetes and obesity treatment

New Jersey-based Amneal Pharma starts mfg operations for Indian market

The firm already has manufacturing units in four Indian cities, all of which are focused on the export market

US-based Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 cr

US-based Amneal Pharmaceuticals Inc on Tuesday said it has acquired Ahmedabad-based drug firm Puniska Healthcare Pvt Ltd for a total value of around Rs 700 crore. The acquisition significantly enhances Amneal's injectables manufacturing infrastructure, capabilities, and capacity to support the US market and serve as a foundation for international markets, the company said in a statement. Puniska includes a 293,000 square foot, manufacturing facility in Ahmedabad, with a number of sterile injectable production lines. Production capabilities include robotic, aseptic and lyophilize vial lines, emulsion line, and large-volume parenteral bag line, it added. The acquisition also brings to the company approximately 550 Puniska employees with key capabilities in injectables manufacturing, R&D and commercialisation, Amneal said. "This acquisition is a pivotal step that meaningfully enhances our injectables capabilities for the US market and enables international expansion, including in ...

Amneal Pharma beats Dr Reddy's in launching limited-competition drug

Amneal's EluRyng is the first generic version of this low competition drug, which the company plans to launch this month

Founded by 2 Gujaratis, US drug major Amneal eyes speciality biz in India

Indo-American brothers Chirag and Chintu Patel have built a $1.8-bn drug giant that is set to pip Sun Pharma as the fifth largest generics maker in the US